PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Coenzyme Q10 and Statin Myalgia: What is the Evidence?

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference - Canadian Journal of Cardiology

Mechanisms of Statin-Induced Myopathy Arteriosclerosis, Thrombosis, and Vascular Biology

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) - Canadian Journal of Cardiology

Novel potassium binders: a clinical update

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

Muscle- and skeletal-related side-effects of statins: tip of the iceberg? - Johann Auer, Helmut Sinzinger, Barry Franklin, Robert Berent, 2016

Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology

The Statinth wonder of the world: a panacea for all illnesses or a bubble about to burst – topic of research paper in Clinical medicine. Download scholarly article PDF and read for